PlainRecalls
FDA Drug Moderate Class II Ongoing

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.

Reported: December 17, 2025 Initiated: October 24, 2025 #D-0218-2026

Product Description

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.

Reason for Recall

Failed stability specifications: Out of specification for hardness test

Details

Recalling Firm
Cipla USA, Inc.
Units Affected
N/A
Distribution
Nationwide in the USA
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.. Recalled by Cipla USA, Inc.. Units affected: N/A.
Why was this product recalled?
Failed stability specifications: Out of specification for hardness test
Which agency issued this recall?
This recall was issued by the FDA Drug on December 17, 2025. Severity: Moderate. Recall number: D-0218-2026.